uniQure (QURE) Net Income towards Common Stockholders (2016 - 2026)
uniQure (QURE) posted Net Income towards Common Stockholders of -$81.1 million for Q2 2026, down 51.41% on a QoQ basis from -$53.5 million in Q1 2026, and down 114.9% year-over-year from $543.9 million in Q2 2025.
Powered by 
Analysis
uniQure (QURE) Net Income towards Common Stockholders (2016 - 2026) Analysis & Trends
uniQure has reported Net Income towards Common Stockholders for 11 years, with the latest figure at -$81.1 million in Q2 2026.
- On a quarterly basis, Net Income towards Common Stockholders fell 114.9% year-over-year to -$81.1 million in Q2 2026; TTM through Jun 2026 was -$196.7 million, a 1.16% increase from a year earlier, with the FY2025 full-year figure at -$199.0 million, up 16.94% from the prior year.
- Net Income towards Common Stockholders was -$81.1 million for Q2 2026 at uniQure, down from -$53.5 million in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $18.4 million in Q4 2025, with the low at -$89.6 million in Q3 2023.
- Average Net Income towards Common Stockholders over 5 years is -$52.9 million, with a median of -$54.9 million recorded in 2024.
- The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders plunged 1175.45% in 2023, then soared 125.15% in 2025.
- Over 5 years, Net Income towards Common Stockholders stood at $6.8 million in 2022, then slumped by 1175.45% to -$73.2 million in 2023, then declined by 0.08% to -$73.3 million in 2024, then soared by 125.15% to $18.4 million in 2025, then sank by 539.89% to -$81.1 million in 2026.
- The last three Net Income towards Common Stockholders figures came in at -$81.1 million (Q2 2026), -$53.5 million (Q1 2026), and $18.4 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -238.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.10 Bn |
| 10 | uniQure | 2.96 Bn | 2.96 Bn | 5.49 Mn | -81.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -81.06 Mn |
| Mar 31, 2026 | -53.54 Mn |
| Dec 31, 2025 | 18.43 Mn |
| Sep 30, 2025 | -80.53 Mn |
| Jun 30, 2025 | -37.72 Mn |
| Mar 31, 2025 | -43.64 Mn |
| Dec 31, 2024 | -73.26 Mn |
| Sep 30, 2024 | -44.38 Mn |
| Jun 30, 2024 | -56.30 Mn |
| Mar 31, 2024 | -65.62 Mn |
| Dec 31, 2023 | -73.21 Mn |
| Sep 30, 2023 | -89.57 Mn |
| Jun 30, 2023 | -68.47 Mn |
| Mar 31, 2023 | -77.23 Mn |
| Dec 31, 2022 | 6.81 Mn |
| Sep 30, 2022 | -47.86 Mn |
| Jun 30, 2022 | -39.06 Mn |
| Mar 31, 2022 | -46.68 Mn |
| Dec 31, 2021 | 8.21 Mn |
| Sep 30, 2021 | -36.53 Mn |
API Access
uniQure Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=QURE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "QURE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=QURE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();